Digital Digital marketing worked. Now pharma must reorganise around ... Remember when I said that patients are coming to doctors with formed opinions – if they come to physicians at all?
News FDA starts swift review of GSK antibiotic for gonorrhoea An oral alternative to injectable treatment for uncomplicated gonorrhoea could be on the way in the US, as FDA starts review of GSK's gepotidacin.
News FDA restricts use of bluebird's Skysona gene therapy The FDA has added a warning label to bluebird bio's Skysona, after launching a probe into cases of blood cancer linked to the gene therapy.
News Vinay Prasad returns to FDA In a new spin on the concept of the FDA's 'revolving door', Vinay Prasad is back as head of CBER, just over a week after leaving the role.
News FDA makes it easier to set up US manufacturing sites The FDA has launched a programme to make it easier to set up manufacturing facilities in the US and reduce the country's reliance on imported drugs.
News New medicines review process under NHS 10-Year Plan emerges More details have emerged of a UK plan for new medicines to get simultaneous decisions from the MHRA and NICE on their use by the NHS.
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
